Clinical Trial Update: Effects of Aspirin Treatment on Fibrin Network Formation in Patients With Type 1 Diabetes [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating whether aspirin affects fibrin network formation in patients with type 1 diabetes. The study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Aspirin (Aspirin)

Snippet

Sponsor: Karolinska Institutet | Conditions: Diabetes Mellitus, Type 1 | Phase 4 | Status: COMPLETED